SABR: Strong Contender for Treating Solitary Kidney Cancer SABR: Strong Contender for Treating Solitary Kidney Cancer

Stereotactic ablative radiotherapy (SABR) provides good local control and causes minimal kidney damage in patients for whom preservation of kidney function is of paramount importance.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news